NCT00242268View on ClinicalTrials.gov

A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis

PHASE3UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2005

Conditions
Relapsing Remitting Multiple Sclerosis
Interventions
DRUG

Simvastatin

Trial Locations (1)

35209

RECRUITING

Alabama Neurology Associates, Birmingham

Sponsors

Collaborators (1)

Biogen
All Listed Sponsors
collaborator

Biogen

INDUSTRY

lead

Alabama Neurology Associates, PC

OTHER